JUNSW
Income statement / Annual
Last year (2021), Jupiter Neurosciences, Inc.'s total revenue was $638,037.00,
a decrease of 43.35% from the previous year.
In 2021, Jupiter Neurosciences, Inc.'s net income was -$4.31 M.
See Jupiter Neurosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$638,037.00
|
$1.13 M
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$638,037.00 |
$1.13 M |
$0.00 |
| Gross Profit Ratio |
1 |
1 |
0 |
| Research and Development
Expenses |
$1.45 M
|
$1.64 M
|
$685,741.00
|
| General & Administrative
Expenses |
$3.10 M
|
$1.34 M
|
$1.49 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$3.10 M
|
$1.34 M
|
$1.49 M
|
| Other Expenses |
$0.00 |
$82,650.00 |
$15,370.00 |
| Operating Expenses |
$4.55 M |
$2.98 M |
$2.18 M |
| Cost And Expenses |
$4.55 M |
$2.98 M |
$2.18 M |
| Interest Income |
$132.00 |
$38.00 |
$4.00 |
| Interest Expense |
$113,994.00 |
$13,535.00 |
$317,104.00 |
| Depreciation &
Amortization |
$132.00
|
$82,688.00
|
$15,374.00
|
| EBITDA |
-$3.91 M
|
-$1.77 M
|
-$2.16 M
|
| EBITDA Ratio |
-6.12 |
-1.57 |
0 |
| Operating Income Ratio
|
-6.12
|
-1.64
|
0
|
| Total Other
Income/Expenses Net |
-$293,162.00
|
$196,895.00
|
-$870,063.00
|
| Income Before Tax |
-$4.20 M |
-$1.65 M |
-$3.05 M |
| Income Before Tax Ratio
|
-6.58
|
-1.47
|
0
|
| Income Tax Expense |
$113,862.00 |
$13,497.00 |
$317,100.00 |
| Net Income |
-$4.31 M |
-$1.67 M |
-$3.36 M |
| Net Income Ratio |
-6.76 |
-1.48 |
0 |
| EPS |
0 |
0 |
0 |
| EPS Diluted |
0 |
0 |
0 |
| Weighted Average Shares
Out |
$0.00
|
$0.00
|
$0.00
|
| Weighted Average Shares
Out Diluted |
$0.00
|
$0.00
|
$0.00
|
| Link |
|
|
|
